Clinical Trials Logo

Clinical Trial Summary

Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.


Clinical Trial Description

According to the CDC, before screening for GBS colonization was implemented, early onset GBS disease occurred at a rate of 1.5-2 per 1,000 live births. Antibiotic treatment for GBS colonized women according to guideline recommended by the American College of Obstetricians and Gynecologists (ACOG) decreases the risk for early onset neonatal GBS infection 10 fold. Unfortunately, many eligible women don't receive the full treatment protocol. Although the rate of early onset infection is low, the newborns of group B strep positive women who do not receive the recommended preventative antibiotics must undergo testing and extended observation.

This study will determine the level of antibiotics in the umbilical vein cord blood of newborn infants after the administration of penicillin orally while in labor and compare these levels to levels of penicillin in the umbilical vein cord blood of patients treated with intravenous penicillin in labor. Comparisons will be done through literature only; there will be no intravenous penicillin administration arm of the study. ;


Study Design

Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00823433
Study type Interventional
Source William Beaumont Hospitals
Contact
Status Terminated
Phase Phase 0
Start date January 2009
Completion date December 2009

See also
  Status Clinical Trial Phase
Recruiting NCT04059510 - Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)
Completed NCT01150123 - Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women Phase 1
Completed NCT02511444 - Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor N/A
Completed NCT00716781 - Management of Infants Born to Group B Streptococcus Positive Mothers. N/A
Completed NCT01982084 - Group B Streptococcus: Attitudes to Immunisation in Pregnancy
Active, not recruiting NCT00972894 - Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study N/A
Completed NCT01251289 - The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
Completed NCT01180023 - Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients N/A
Completed NCT00008853 - Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines Phase 1